Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
01/1991
01/02/1991EP0405315A2 Use of a phagocyte-activating agent : LPS or IL-2 for the manufacture of a medicament for treating staphylococcus aureus infection in cows
01/02/1991EP0405242A2 VIP-Analogs II
01/02/1991EP0404912A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
01/02/1991EP0404836A1 Human monoclonal antibodies against rabies virus
01/02/1991EP0404812A1 Recombinant igf binding protein (ibp-1)
01/02/1991EP0382841A4 Wound healing
01/02/1991CA1278650C Process for the low-racemization preparation of peptide intermediates of the synthesis of gonadorelin and gonadorelin analogs, and new intermediates for this process
01/02/1991CA1278515C Pharmaceutical composition for combination therapy of hormone dependent cancers
01/01/1991US4981956 DNA sequences encoding bovine growth factors
01/01/1991US4981950 Hypotensive
01/01/1991US4981846 Crystalline L-carnosine zinc complex having antiulcer activity
01/01/1991US4981843 N-heterocyclic alcohol derivatives
01/01/1991US4981842 Antitumor peptides
12/1990
12/31/1990WO1991000356A1 Inhibition of the n-end rule pathway in living cells
12/31/1990WO1991000350A1 Nonglycosylated human interleukin-3 analog proteins
12/31/1990WO1991000287A1 Enhancement of musculature in animals
12/31/1990CA2033182A1 Nonglycosylated human interleukin-3 analog proteins
12/31/1990CA2020129A1 Analogues of all-bond retroinverted thymopentin, the method for the synthesis of the same and their employment for the preparation of pharmaceutical compositions
12/31/1990CA2020065A1 Tetrapeptide type-b cck receptor ligands
12/31/1990CA2020063A1 Antibiotic agent
12/31/1990CA2019970A1 Vip-analogs ii
12/31/1990CA2019408A1 Lymphocyte-activating factor, method for the preparation thereof and method for the proliferation of antibody-forming lymphocytes and production of antibody using the same
12/30/1990WO1991000293A1 Vasodilatory and immune suppressant peptides
12/30/1990CA2063260A1 Vasodilatory and immune suppressant peptides
12/30/1990CA2020053A1 Hair growth composition
12/29/1990CA2019922A1 Muramyl dipeptide derivatives
12/29/1990CA2019633A1 Peptide derivatives, process for their preparation and pharmaceutical compositions containing the same
12/28/1990WO1991000872A1 Monoclonal antibodies to c-reactive protein
12/27/1990WO1990015871A1 Expression of tetanus toxin fragment c
12/27/1990WO1990015867A1 Human prourokinase-like polypeptides and their preparation methods
12/27/1990WO1990015822A1 Monoclonal antibody to intracellular epitope of human t cell receptor zeta chain and method of preparation
12/27/1990WO1990015817A1 Interferon purification process
12/27/1990WO1990015815A1 Gamma retinoic acid receptor
12/27/1990WO1990015627A1 Methods and compositions for the preparation and use of site-directed immunologic reagents
12/27/1990WO1990015620A1 Platelet aggregation inhibitors
12/27/1990WO1990015617A1 Albumin preparation and method of producing the same
12/27/1990WO1990015616A1 Remedy for pancreatitis
12/27/1990WO1990015615A1 The phospholipid binding domain of factor viii
12/27/1990WO1990015614A1 ANTIGENIC EPITOPES PRESENT ON MEMBRANE-BOUND BUT NOT SECRETED IgA
12/27/1990EP0404660A2 Use of glycoprotein complex extracts of gram (-) bacteria for the preparation of a medicament to facilitate the cicatrisation of the skin and a method for its preparation
12/27/1990EP0404652A1 Novel hypothalamic polypeptides with adenylate cyclase stimulating activity
12/27/1990EP0404458A2 Ovine follicle stimulating hormone
12/27/1990EP0404300A2 Process for production of eicosapentaenoic acid-containing phospholipids
12/27/1990EP0404097A2 Bispecific and oligospecific, mono- and oligovalent receptors, production and applications thereof
12/27/1990EP0404055A1 Ghilanten: antimetastatic principle from the south american leech, haementeria ghilianii
12/27/1990EP0404034A2 Novel DNA and use thereof
12/27/1990EP0404003A2 Chimeric mouse-human KM10 antibody with specificity to a human tumor cell antigen
12/27/1990EP0403961A2 Magnetic protein conjugates, process to make them and their use
12/27/1990EP0403960A2 Magnetic protein conjugates, method to make them and their use
12/27/1990EP0403935A1 Use of a monoclonal antibody for the treatment of an auto-immune disease
12/27/1990EP0403828A1 Renin-inhibiting peptides, their preparation and their use in medicaments
12/27/1990EP0403748A2 Oral lipid medicinal form
12/27/1990EP0403605A1 Elastase inhibiting polymers and methods
12/27/1990EP0403601A1 Novel somatotropins.
12/27/1990EP0403598A1 tPA-LIKE POLYPEPTIDES, THEIR MANUFACTURE AND USE
12/27/1990EP0403597A1 Expandable, protein-based, low-calorie compositions
12/27/1990EP0403559A1 Improvements relating to antigens
12/27/1990EP0257084B1 Use of a dipeptide with cell growth regulating effect for the preparation of a medicament
12/27/1990EP0229108B1 Solubilization of proteins for pharmaceutical compositions using polymer conjugation
12/27/1990EP0214995B1 Immunotoxin and method of making
12/27/1990CA2388770A1 Platelet aggregation inhibitors
12/27/1990CA2066692A1 Gamma retinoic acid receptor
12/27/1990CA2019714A1 Process for the determination of interleukins
12/27/1990CA1278212C Compound comprising polymethionyl-polylysine for animal feed
12/26/1990CA2019259A1 Use of isoxazolin-3-one derivatives as antidepressants
12/25/1990US4980457 Coupling of ricin and antibody
12/25/1990US4980456 Recombinant factor VIIIC derived fragments
12/25/1990US4980455 Novel polypeptides and production thereof
12/25/1990US4980450 Phosphopeptides from casein-based raw material
12/25/1990US4980343 Aminooxodihydroisoindoloquinazoline carcinostatic agents
12/25/1990US4980286 In vivo introduction and expression of foreign genetic material in epithelial cells
12/25/1990US4980166 Administering follicle-stimulating hormone
12/25/1990US4980165 Pharmaceutical formulations of plasminogen activator proteins
12/25/1990US4980163 Lysostaphin and lanthionine containing bacteriocin
12/25/1990US4980160 High dosage of tumor necrosis factor possible
12/25/1990US4980149 Reduction of the toxic effects caused by anthraquinone drugs
12/25/1990CA2019661A1 Modified vp1/p2a region of the rhinovirus system
12/24/1990WO1991000102A1 Combined use of n-imidazolyl derivatives of bicyclic compounds and cyclosporine in therapy
12/24/1990CA2035032A1 Combined use of n-imidazolyl derivatives of bicyclic compounds and cyclosporine in therapy
12/23/1990WO1990015618A2 Srif-related peptides and uses thereof
12/23/1990CA2059280A1 Srif-related peptides and uses thereof
12/22/1990WO1990015872A1 Recombinant poxvirus and streptococcal m protein vaccine
12/22/1990CA2013614A1 Process for production of eicosapentaenoic acid-containing phospholipid and use of said lipid
12/20/1990DE3919658A1 Treatment of wound healing disorders - with tumour necrosis factor or lymphotoxin
12/19/1990EP0403458A1 Novel polypeptides and their use
12/19/1990EP0403312A1 Immunoactive peptides and antibodies and their use in anti-allergy treatment
12/19/1990EP0403243A1 Chelate derivatives of atrial natriuretic factor (ANF)
12/19/1990EP0403172A2 Purified enzyme and process therefor
12/19/1990EP0403156A1 Improved monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use
12/19/1990EP0403114A1 Interleukin-7 receptors
12/19/1990EP0403032A2 Method for prolonged release of somatotropin
12/19/1990EP0402852A1 Irreversible bombesin antagonists
12/19/1990EP0402646A1 Retroviral protease inhibiting compounds
12/19/1990EP0402544A1 Nucleotide sequence encoding plant ribosome inactivating protein
12/19/1990CN1047870A Renin-inhibiting peptides, processes for their preparation and their use in medicaments
12/19/1990CA2019323A1 Chimeric mouse-human km10 antibody with specificity to a human tumor cell antigen
12/19/1990CA2019239A1 Ovine follicle stimulating hormone
12/19/1990CA2019217A1 Magnetic protein conjugates, a process for the preparation thereof and the use thereof
12/18/1990US4978745 Immunoreactive heterochain antibodies
12/18/1990US4978620 Adsorption on erythrina trypsin inhibitor-bearing carrier and eluting at different acidity